Lazard Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,075
Closed -$236K 2166
2021
Q2
$236K Buy
+7,075
New +$236K ﹤0.01% 1196